Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data

Fig. 3

Validation of the nomogram for predicting OS of patients with Siewert type II/III AEG. a The time-dependent ROC analysis showed the AUC of this nomogram in the validation-1 cohort was 0.833 at 2-year, 0.874 at 3-year, and 0.858 at 5-year. b The time-dependent ROC analysis showed AUC of this nomogram in the validation-2 cohort was 0.793 at 2-year and 0.76 at 3-year. c Calibration plots showed the predicted survival probability at 2-, 3- and 5-year was well consistent with that observed in the validation-1 cohort. d Calibration plots showed the predicted probability of survival at 2- and 3-year was well consistent with that observed in the validation-2 cohort

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us